pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    deupirfenidone
    deupirfenidone
    Idiopathic Pulmonary Fibrosis Celea Therapeutics
  • Phase 2
    devimistat
    devimistat [INN]
    Bile Duct Cancer (Cholangiocarcinoma) Cornerstone Pharmaceuticals Inc
  • Phase 2
    dibotatug
    dibotatug
    Leukemia Dren Bio Inc
  • Phase 2
← prev
page 35 of 50
next →
131
Pain89
Neurology1
dilanubicel
dilanubicel
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Deverra Therapeutics Inc
  • Phase 2
    dimesna
    dimesna [INN]
    Non-Small Cell Lung Cancer$LTRN Lantern Pharma Inc.
  • Phase 2
    dimethyltryptamine
    dimethyltryptamine
    Treatment Resistant Depression$ATAI AtaiBeckley Inc.
  • Phase 2
    dinutuximab beta
    dinutuximab beta [INN]
    Ewing Sarcoma Recordati SpA
  • Phase 2
    diranersen
    diranersen [INN]
    Alzheimer's Disease$BIIB BIOGEN INC.
  • Phase 2
    disitamab vedotin
    disitamab vedotin
    Metastatic Transitional (Urothelial) Tract Cancer$PFE PFIZER INC
  • Phase 2
    disufenton sodium
    disufenton sodium
    Recurrent Malignant Glioma Oblato Inc
  • Phase 2
    divesiran
    divesiran [INN]
    Polycythemia Vera$SLN Silence Therapeutics plc
  • Phase 2
    dorocubicel
    dorocubicel
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Cordex Biologics Inc
  • Phase 2
    dronabinol + palmidrol
    dronabinol + palmidrol [INN]
    Tourette Syndrome Evero Health Ltd
  • Phase 2
    dubodencel
    dubodencel [INN]
    Glioblastoma Multiforme (GBM) Diakonos Oncology Corp
  • Phase 2
    durvalumab + IPH-5201
    Non-Small Cell Lung Cancer$AZN ASTRAZENECA PLC
  • Phase 2
    dutogliptin tartrate
    dutogliptin tartrate
    Post-Myocardial Infarction Recardio Inc
  • Phase 2
    duvalgagene otiparvovec
    duvalgagene otiparvovec
    Fabry Disease$FDMT 4D Molecular Therapeutics, Inc.
  • Phase 2
    efarindodekin alfa
    efarindodekin alfa[INN]
    Cervical Cancer$GILD GILEAD SCIENCES, INC.
  • Phase 2
    efdoralprin alfa
    efdoralprin alfa [INN]
    Alpha-1 Antitrypsin Deficiency (A1AD)$SNY Sanofi
  • Phase 2
    efgitasialase alfa
    efgitasialase alfa
    Breast Cancer Palleon Pharmaceuticals Inc
  • Phase 2
    efineptakin alfa
    efineptakin alfa
    Radiation Toxicity (Radiation Sickness, Acute Radiation S… NeoImmuneTech Inc
  • Phase 2
    efinopegdutide
    efinopegdutide
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or…$MRK Merck & Co., Inc.
  • Phase 2
    efocipegtrutide
    efocipegtrutide [INN]
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Hanmi Pharmaceuticals Co Ltd
  • Phase 2
    efpegerglucagon
    efpegerglucagon [INN]
    Hyperinsulinemia Hanmi Pharmaceuticals Co Ltd
  • Phase 2
    efzofitimod
    efzofitimod [INN]
    Interstitial Lung Diseases (Diffuse Parenchymal Lung Dise…$ATYR aTYR PHARMA INC
  • Phase 2
    egalognastat
    egalognastat [INN]
    Progressive Supranuclear Palsy Grupo Ferrer Internacional SA
  • Phase 2
    elecoglipron
    elecoglipron
    Type 2 Diabetes$AZN ASTRAZENECA PLC
  • Phase 2
    elezanumab
    elezanumab
    Traumatic Spinal Cord Injury$ABBV AbbVie Inc.
  • Phase 2
    elifactant
    elifactant
    Neonatal Respiratory Distress Syndrome Chiesi Farmaceutici SpA
  • Phase 2
    elironrasib
    elironrasib
    Non-Small Cell Lung Cancer$RVMD Revolution Medicines, Inc.